id 64
investor_company_id 144
sector_category_id 9
focus_type secondary
weight_pct
source curated
confidence high
evidence_count
notes Biotech with biodefense relevance
created_at 2026-05-22T18:48:09.803216+00:00
updated_at 2026-05-22T23:25:44.300201+00:00
tenant_id 1